Strategies for proprotein convertase subtilisin kexin 9 modulation: a perspective on recent patents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Strategies for proprotein convertase subtilisin kexin 9 modulation: a perspective on recent patents

Published:2010-09-17 Issue:11 Volume:20 Page:1547-1571
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Abifadel Marianne,Pakradouni Jihane,Collin Matthieu,Samson-Bouma Marie-Elisabeth,Varret Mathilde,Rabès Jean-Pierre,Boileau Catherine

Publisher

Informa Healthcare

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/13543776.2010.518615

Reference71 articles.

1. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

2. Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.

3. A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree

4. Novel mutations of thePCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Degree of serum LDL cholesterol reduction by simvastatin and ezetimibe is dependent on baseline LDL cholesterol concentration but not on baseline values and changes in cholesterol synthesis and absorption parameters;Int. Journal of Clinical Pharmacology and Therapeutics;2024-07-01

2. PCSK9 inhibitors: a patent review 2018-2023;Expert Opinion on Therapeutic Patents;2024-04-02

3. Genetic and molecular architecture of familial hypercholesterolemia;Journal of Internal Medicine;2022-10-17

4. Low circulating PCSK9 levels in LPL homozygous children with chylomicronemia syndrome in a syrian refugee family in Lebanon;Frontiers in Genetics;2022-08-19

5. A multi-scale model for low-density lipoprotein cholesterol (LDL-C) regulation in the human body: Application to quantitative systems pharmacology;Computers & Chemical Engineering;2019-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3